Potential therapeutic implications of histidine catabolism by the gut microbiota in NAFLD patients with morbid obesity. (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.xcrm.2023.101341
PubMed Identifier: 38118419
Publication URI: http://europepmc.org/abstract/MED/38118419
Type: Journal Article/Review
Volume: 4
Parent Publication: Cell reports. Medicine
Issue: 12
ISSN: 2666-3791